nodes	percent_of_prediction	percent_of_DWPC	metapath
Galantamine—BCHE—Triamcinolone—psoriatic arthritis	0.274	0.519	CbGbCtD
Galantamine—CYP3A4—Methylprednisolone—psoriatic arthritis	0.055	0.104	CbGbCtD
Galantamine—CYP3A4—Triamcinolone—psoriatic arthritis	0.0417	0.0789	CbGbCtD
Galantamine—CYP3A4—Betamethasone—psoriatic arthritis	0.0358	0.0677	CbGbCtD
Galantamine—CYP3A4—Prednisolone—psoriatic arthritis	0.0353	0.0668	CbGbCtD
Galantamine—CYP3A4—Prednisone—psoriatic arthritis	0.0333	0.063	CbGbCtD
Galantamine—CYP2D6—Dexamethasone—psoriatic arthritis	0.0327	0.0619	CbGbCtD
Galantamine—CYP3A4—Dexamethasone—psoriatic arthritis	0.0208	0.0394	CbGbCtD
Galantamine—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.000834	0.00177	CcSEcCtD
Galantamine—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.000832	0.00177	CcSEcCtD
Galantamine—Shock—Prednisolone—psoriatic arthritis	0.000828	0.00176	CcSEcCtD
Galantamine—Cough—Triamcinolone—psoriatic arthritis	0.000828	0.00176	CcSEcCtD
Galantamine—Convulsion—Triamcinolone—psoriatic arthritis	0.000822	0.00174	CcSEcCtD
Galantamine—Tachycardia—Prednisolone—psoriatic arthritis	0.000821	0.00174	CcSEcCtD
Galantamine—Convulsion—Methylprednisolone—psoriatic arthritis	0.00082	0.00174	CcSEcCtD
Galantamine—Hypertension—Triamcinolone—psoriatic arthritis	0.000819	0.00174	CcSEcCtD
Galantamine—Hypertension—Methylprednisolone—psoriatic arthritis	0.000817	0.00173	CcSEcCtD
Galantamine—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000814	0.00173	CcSEcCtD
Galantamine—Myalgia—Triamcinolone—psoriatic arthritis	0.000807	0.00171	CcSEcCtD
Galantamine—Pneumonia—Methotrexate—psoriatic arthritis	0.000806	0.00171	CcSEcCtD
Galantamine—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000806	0.00171	CcSEcCtD
Galantamine—Myalgia—Methylprednisolone—psoriatic arthritis	0.000806	0.00171	CcSEcCtD
Galantamine—Eye disorder—Prednisone—psoriatic arthritis	0.000805	0.00171	CcSEcCtD
Galantamine—Anxiety—Methylprednisolone—psoriatic arthritis	0.000803	0.0017	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.0008	0.0017	CcSEcCtD
Galantamine—Depression—Methotrexate—psoriatic arthritis	0.000799	0.0017	CcSEcCtD
Galantamine—Flushing—Prednisone—psoriatic arthritis	0.000799	0.0017	CcSEcCtD
Galantamine—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000798	0.0017	CcSEcCtD
Galantamine—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000798	0.0017	CcSEcCtD
Galantamine—Discomfort—Triamcinolone—psoriatic arthritis	0.000798	0.00169	CcSEcCtD
Galantamine—Discomfort—Methylprednisolone—psoriatic arthritis	0.000796	0.00169	CcSEcCtD
Galantamine—Dry mouth—Triamcinolone—psoriatic arthritis	0.00079	0.00168	CcSEcCtD
Galantamine—Renal failure—Methotrexate—psoriatic arthritis	0.000788	0.00167	CcSEcCtD
Galantamine—Angiopathy—Prednisone—psoriatic arthritis	0.000781	0.00166	CcSEcCtD
Galantamine—Confusional state—Methylprednisolone—psoriatic arthritis	0.000779	0.00165	CcSEcCtD
Galantamine—Immune system disorder—Prednisone—psoriatic arthritis	0.000778	0.00165	CcSEcCtD
Galantamine—Malaise—Dexamethasone—psoriatic arthritis	0.000776	0.00165	CcSEcCtD
Galantamine—Malaise—Betamethasone—psoriatic arthritis	0.000776	0.00165	CcSEcCtD
Galantamine—Vertigo—Dexamethasone—psoriatic arthritis	0.000773	0.00164	CcSEcCtD
Galantamine—Vertigo—Betamethasone—psoriatic arthritis	0.000773	0.00164	CcSEcCtD
Galantamine—Syncope—Betamethasone—psoriatic arthritis	0.000772	0.00164	CcSEcCtD
Galantamine—Syncope—Dexamethasone—psoriatic arthritis	0.000772	0.00164	CcSEcCtD
Galantamine—Arrhythmia—Prednisone—psoriatic arthritis	0.000769	0.00163	CcSEcCtD
Galantamine—Haematuria—Methotrexate—psoriatic arthritis	0.000764	0.00162	CcSEcCtD
Galantamine—Shock—Triamcinolone—psoriatic arthritis	0.000762	0.00162	CcSEcCtD
Galantamine—Insomnia—Prednisolone—psoriatic arthritis	0.000761	0.00162	CcSEcCtD
Galantamine—Shock—Methylprednisolone—psoriatic arthritis	0.00076	0.00161	CcSEcCtD
Galantamine—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000758	0.00161	CcSEcCtD
Galantamine—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000757	0.00161	CcSEcCtD
Galantamine—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000756	0.00161	CcSEcCtD
Galantamine—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000756	0.00161	CcSEcCtD
Galantamine—Epistaxis—Methotrexate—psoriatic arthritis	0.000756	0.0016	CcSEcCtD
Galantamine—Paraesthesia—Prednisolone—psoriatic arthritis	0.000756	0.0016	CcSEcCtD
Galantamine—Tachycardia—Triamcinolone—psoriatic arthritis	0.000755	0.0016	CcSEcCtD
Galantamine—Mental disorder—Prednisone—psoriatic arthritis	0.000754	0.0016	CcSEcCtD
Galantamine—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000754	0.0016	CcSEcCtD
Galantamine—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00075	0.00159	CcSEcCtD
Galantamine—Malnutrition—Prednisone—psoriatic arthritis	0.000749	0.00159	CcSEcCtD
Galantamine—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000748	0.00159	CcSEcCtD
Galantamine—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000747	0.00158	CcSEcCtD
Galantamine—Convulsion—Betamethasone—psoriatic arthritis	0.000746	0.00158	CcSEcCtD
Galantamine—Convulsion—Dexamethasone—psoriatic arthritis	0.000746	0.00158	CcSEcCtD
Galantamine—Hypertension—Dexamethasone—psoriatic arthritis	0.000743	0.00158	CcSEcCtD
Galantamine—Hypertension—Betamethasone—psoriatic arthritis	0.000743	0.00158	CcSEcCtD
Galantamine—Myalgia—Dexamethasone—psoriatic arthritis	0.000733	0.00156	CcSEcCtD
Galantamine—Myalgia—Betamethasone—psoriatic arthritis	0.000733	0.00156	CcSEcCtD
Galantamine—Anxiety—Dexamethasone—psoriatic arthritis	0.00073	0.00155	CcSEcCtD
Galantamine—Anxiety—Betamethasone—psoriatic arthritis	0.00073	0.00155	CcSEcCtD
Galantamine—Discomfort—Betamethasone—psoriatic arthritis	0.000724	0.00154	CcSEcCtD
Galantamine—Discomfort—Dexamethasone—psoriatic arthritis	0.000724	0.00154	CcSEcCtD
Galantamine—Haemoglobin—Methotrexate—psoriatic arthritis	0.000723	0.00154	CcSEcCtD
Galantamine—Hypotension—Methylprednisolone—psoriatic arthritis	0.000722	0.00153	CcSEcCtD
Galantamine—Haemorrhage—Methotrexate—psoriatic arthritis	0.000719	0.00153	CcSEcCtD
Galantamine—Hepatitis—Methotrexate—psoriatic arthritis	0.000719	0.00153	CcSEcCtD
Galantamine—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000711	0.00151	CcSEcCtD
Galantamine—Vision blurred—Prednisone—psoriatic arthritis	0.000706	0.0015	CcSEcCtD
Galantamine—Urethral disorder—Methotrexate—psoriatic arthritis	0.000705	0.0015	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000705	0.0015	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000704	0.00149	CcSEcCtD
Galantamine—Insomnia—Triamcinolone—psoriatic arthritis	0.0007	0.00149	CcSEcCtD
Galantamine—Insomnia—Methylprednisolone—psoriatic arthritis	0.000699	0.00148	CcSEcCtD
Galantamine—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000695	0.00148	CcSEcCtD
Galantamine—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000695	0.00148	CcSEcCtD
Galantamine—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000694	0.00147	CcSEcCtD
Galantamine—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000693	0.00147	CcSEcCtD
Galantamine—Visual impairment—Methotrexate—psoriatic arthritis	0.000693	0.00147	CcSEcCtD
Galantamine—Anaemia—Prednisone—psoriatic arthritis	0.000693	0.00147	CcSEcCtD
Galantamine—Shock—Betamethasone—psoriatic arthritis	0.000691	0.00147	CcSEcCtD
Galantamine—Shock—Dexamethasone—psoriatic arthritis	0.000691	0.00147	CcSEcCtD
Galantamine—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000689	0.00146	CcSEcCtD
Galantamine—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000689	0.00146	CcSEcCtD
Galantamine—Agitation—Prednisone—psoriatic arthritis	0.000689	0.00146	CcSEcCtD
Galantamine—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000688	0.00146	CcSEcCtD
Galantamine—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000688	0.00146	CcSEcCtD
Galantamine—Tachycardia—Dexamethasone—psoriatic arthritis	0.000685	0.00146	CcSEcCtD
Galantamine—Tachycardia—Betamethasone—psoriatic arthritis	0.000685	0.00146	CcSEcCtD
Galantamine—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000681	0.00145	CcSEcCtD
Galantamine—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00068	0.00144	CcSEcCtD
Galantamine—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000679	0.00144	CcSEcCtD
Galantamine—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000679	0.00144	CcSEcCtD
Galantamine—Malaise—Prednisone—psoriatic arthritis	0.000676	0.00143	CcSEcCtD
Galantamine—Vertigo—Prednisone—psoriatic arthritis	0.000673	0.00143	CcSEcCtD
Galantamine—Eye disorder—Methotrexate—psoriatic arthritis	0.000672	0.00143	CcSEcCtD
Galantamine—Syncope—Prednisone—psoriatic arthritis	0.000672	0.00143	CcSEcCtD
Galantamine—Tinnitus—Methotrexate—psoriatic arthritis	0.000671	0.00142	CcSEcCtD
Galantamine—Anorexia—Betamethasone—psoriatic arthritis	0.000669	0.00142	CcSEcCtD
Galantamine—Anorexia—Dexamethasone—psoriatic arthritis	0.000669	0.00142	CcSEcCtD
Galantamine—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000668	0.00142	CcSEcCtD
Galantamine—Fatigue—Triamcinolone—psoriatic arthritis	0.000667	0.00142	CcSEcCtD
Galantamine—Fatigue—Methylprednisolone—psoriatic arthritis	0.000666	0.00141	CcSEcCtD
Galantamine—Loss of consciousness—Prednisone—psoriatic arthritis	0.000659	0.0014	CcSEcCtD
Galantamine—Hypotension—Dexamethasone—psoriatic arthritis	0.000656	0.00139	CcSEcCtD
Galantamine—Hypotension—Betamethasone—psoriatic arthritis	0.000656	0.00139	CcSEcCtD
Galantamine—Angiopathy—Methotrexate—psoriatic arthritis	0.000653	0.00139	CcSEcCtD
Galantamine—Immune system disorder—Methotrexate—psoriatic arthritis	0.00065	0.00138	CcSEcCtD
Galantamine—Convulsion—Prednisone—psoriatic arthritis	0.000649	0.00138	CcSEcCtD
Galantamine—Hypertension—Prednisone—psoriatic arthritis	0.000647	0.00137	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00064	0.00136	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00064	0.00136	CcSEcCtD
Galantamine—Myalgia—Prednisone—psoriatic arthritis	0.000638	0.00135	CcSEcCtD
Galantamine—Arthralgia—Prednisone—psoriatic arthritis	0.000638	0.00135	CcSEcCtD
Galantamine—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000638	0.00135	CcSEcCtD
Galantamine—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000636	0.00135	CcSEcCtD
Galantamine—Anxiety—Prednisone—psoriatic arthritis	0.000636	0.00135	CcSEcCtD
Galantamine—Insomnia—Betamethasone—psoriatic arthritis	0.000635	0.00135	CcSEcCtD
Galantamine—Insomnia—Dexamethasone—psoriatic arthritis	0.000635	0.00135	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000634	0.00135	CcSEcCtD
Galantamine—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000632	0.00134	CcSEcCtD
Galantamine—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000631	0.00134	CcSEcCtD
Galantamine—Paraesthesia—Betamethasone—psoriatic arthritis	0.000631	0.00134	CcSEcCtD
Galantamine—Discomfort—Prednisone—psoriatic arthritis	0.00063	0.00134	CcSEcCtD
Galantamine—Mental disorder—Methotrexate—psoriatic arthritis	0.00063	0.00134	CcSEcCtD
Galantamine—Malnutrition—Methotrexate—psoriatic arthritis	0.000626	0.00133	CcSEcCtD
Galantamine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00062	0.00132	CcSEcCtD
Galantamine—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000618	0.00131	CcSEcCtD
Galantamine—Dyspepsia—Betamethasone—psoriatic arthritis	0.000618	0.00131	CcSEcCtD
Galantamine—Dysgeusia—Methotrexate—psoriatic arthritis	0.000613	0.0013	CcSEcCtD
Galantamine—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000612	0.0013	CcSEcCtD
Galantamine—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000611	0.0013	CcSEcCtD
Galantamine—Decreased appetite—Betamethasone—psoriatic arthritis	0.000611	0.0013	CcSEcCtD
Galantamine—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000611	0.0013	CcSEcCtD
Galantamine—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000606	0.00129	CcSEcCtD
Galantamine—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000606	0.00129	CcSEcCtD
Galantamine—Back pain—Methotrexate—psoriatic arthritis	0.000606	0.00129	CcSEcCtD
Galantamine—Fatigue—Betamethasone—psoriatic arthritis	0.000605	0.00129	CcSEcCtD
Galantamine—Fatigue—Dexamethasone—psoriatic arthritis	0.000605	0.00129	CcSEcCtD
Galantamine—Shock—Prednisone—psoriatic arthritis	0.000602	0.00128	CcSEcCtD
Galantamine—Nervous system disorder—Prednisone—psoriatic arthritis	0.0006	0.00127	CcSEcCtD
Galantamine—Tachycardia—Prednisone—psoriatic arthritis	0.000597	0.00127	CcSEcCtD
Galantamine—Skin disorder—Prednisone—psoriatic arthritis	0.000594	0.00126	CcSEcCtD
Galantamine—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000591	0.00126	CcSEcCtD
Galantamine—Vision blurred—Methotrexate—psoriatic arthritis	0.00059	0.00125	CcSEcCtD
Galantamine—Anorexia—Prednisone—psoriatic arthritis	0.000583	0.00124	CcSEcCtD
Galantamine—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000581	0.00123	CcSEcCtD
Galantamine—Anaemia—Methotrexate—psoriatic arthritis	0.000579	0.00123	CcSEcCtD
Galantamine—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000579	0.00123	CcSEcCtD
Galantamine—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000579	0.00123	CcSEcCtD
Galantamine—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000574	0.00122	CcSEcCtD
Galantamine—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000574	0.00122	CcSEcCtD
Galantamine—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00057	0.00121	CcSEcCtD
Galantamine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000569	0.00121	CcSEcCtD
Galantamine—Malaise—Methotrexate—psoriatic arthritis	0.000565	0.0012	CcSEcCtD
Galantamine—Vertigo—Methotrexate—psoriatic arthritis	0.000563	0.00119	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000557	0.00118	CcSEcCtD
Galantamine—Dizziness—Prednisolone—psoriatic arthritis	0.000557	0.00118	CcSEcCtD
Galantamine—Asthenia—Triamcinolone—psoriatic arthritis	0.000555	0.00118	CcSEcCtD
Galantamine—Abdominal pain—Betamethasone—psoriatic arthritis	0.000555	0.00118	CcSEcCtD
Galantamine—Body temperature increased—Betamethasone—psoriatic arthritis	0.000555	0.00118	CcSEcCtD
Galantamine—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000555	0.00118	CcSEcCtD
Galantamine—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000555	0.00118	CcSEcCtD
Galantamine—Asthenia—Methylprednisolone—psoriatic arthritis	0.000554	0.00118	CcSEcCtD
Galantamine—Insomnia—Prednisone—psoriatic arthritis	0.000553	0.00117	CcSEcCtD
Galantamine—Paraesthesia—Prednisone—psoriatic arthritis	0.000549	0.00117	CcSEcCtD
Galantamine—Cough—Methotrexate—psoriatic arthritis	0.000547	0.00116	CcSEcCtD
Galantamine—Convulsion—Methotrexate—psoriatic arthritis	0.000543	0.00115	CcSEcCtD
Galantamine—Dyspepsia—Prednisone—psoriatic arthritis	0.000538	0.00114	CcSEcCtD
Galantamine—Myalgia—Methotrexate—psoriatic arthritis	0.000533	0.00113	CcSEcCtD
Galantamine—Chest pain—Methotrexate—psoriatic arthritis	0.000533	0.00113	CcSEcCtD
Galantamine—Arthralgia—Methotrexate—psoriatic arthritis	0.000533	0.00113	CcSEcCtD
Galantamine—Decreased appetite—Prednisone—psoriatic arthritis	0.000532	0.00113	CcSEcCtD
Galantamine—Rash—Prednisolone—psoriatic arthritis	0.000531	0.00113	CcSEcCtD
Galantamine—Dermatitis—Prednisolone—psoriatic arthritis	0.00053	0.00113	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.00053	0.00112	CcSEcCtD
Galantamine—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000528	0.00112	CcSEcCtD
Galantamine—Fatigue—Prednisone—psoriatic arthritis	0.000527	0.00112	CcSEcCtD
Galantamine—Headache—Prednisolone—psoriatic arthritis	0.000527	0.00112	CcSEcCtD
Galantamine—Discomfort—Methotrexate—psoriatic arthritis	0.000527	0.00112	CcSEcCtD
Galantamine—Constipation—Prednisone—psoriatic arthritis	0.000523	0.00111	CcSEcCtD
Galantamine—Confusional state—Methotrexate—psoriatic arthritis	0.000515	0.00109	CcSEcCtD
Galantamine—Dizziness—Triamcinolone—psoriatic arthritis	0.000512	0.00109	CcSEcCtD
Galantamine—Dizziness—Methylprednisolone—psoriatic arthritis	0.000511	0.00108	CcSEcCtD
Galantamine—Feeling abnormal—Prednisone—psoriatic arthritis	0.000504	0.00107	CcSEcCtD
Galantamine—Asthenia—Betamethasone—psoriatic arthritis	0.000504	0.00107	CcSEcCtD
Galantamine—Asthenia—Dexamethasone—psoriatic arthritis	0.000504	0.00107	CcSEcCtD
Galantamine—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000501	0.00106	CcSEcCtD
Galantamine—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.0005	0.00106	CcSEcCtD
Galantamine—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.0005	0.00106	CcSEcCtD
Galantamine—Nausea—Prednisolone—psoriatic arthritis	0.0005	0.00106	CcSEcCtD
Galantamine—Skin disorder—Methotrexate—psoriatic arthritis	0.000496	0.00105	CcSEcCtD
Galantamine—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000494	0.00105	CcSEcCtD
Galantamine—Vomiting—Triamcinolone—psoriatic arthritis	0.000492	0.00104	CcSEcCtD
Galantamine—Vomiting—Methylprednisolone—psoriatic arthritis	0.000491	0.00104	CcSEcCtD
Galantamine—Rash—Triamcinolone—psoriatic arthritis	0.000488	0.00104	CcSEcCtD
Galantamine—Dermatitis—Triamcinolone—psoriatic arthritis	0.000488	0.00104	CcSEcCtD
Galantamine—Anorexia—Methotrexate—psoriatic arthritis	0.000487	0.00103	CcSEcCtD
Galantamine—Rash—Methylprednisolone—psoriatic arthritis	0.000487	0.00103	CcSEcCtD
Galantamine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000486	0.00103	CcSEcCtD
Galantamine—Headache—Triamcinolone—psoriatic arthritis	0.000485	0.00103	CcSEcCtD
Galantamine—Headache—Methylprednisolone—psoriatic arthritis	0.000484	0.00103	CcSEcCtD
Galantamine—Abdominal pain—Prednisone—psoriatic arthritis	0.000483	0.00103	CcSEcCtD
Galantamine—Body temperature increased—Prednisone—psoriatic arthritis	0.000483	0.00103	CcSEcCtD
Galantamine—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000481	0.00102	CcSEcCtD
Galantamine—Diarrhoea—Betamethasone—psoriatic arthritis	0.000481	0.00102	CcSEcCtD
Galantamine—Hypotension—Methotrexate—psoriatic arthritis	0.000478	0.00101	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000466	0.000989	CcSEcCtD
Galantamine—Dizziness—Dexamethasone—psoriatic arthritis	0.000464	0.000986	CcSEcCtD
Galantamine—Dizziness—Betamethasone—psoriatic arthritis	0.000464	0.000986	CcSEcCtD
Galantamine—Insomnia—Methotrexate—psoriatic arthritis	0.000462	0.000981	CcSEcCtD
Galantamine—Nausea—Triamcinolone—psoriatic arthritis	0.00046	0.000976	CcSEcCtD
Galantamine—Paraesthesia—Methotrexate—psoriatic arthritis	0.000459	0.000974	CcSEcCtD
Galantamine—Nausea—Methylprednisolone—psoriatic arthritis	0.000459	0.000974	CcSEcCtD
Galantamine—Somnolence—Methotrexate—psoriatic arthritis	0.000454	0.000965	CcSEcCtD
Galantamine—Hypersensitivity—Prednisone—psoriatic arthritis	0.000451	0.000957	CcSEcCtD
Galantamine—Dyspepsia—Methotrexate—psoriatic arthritis	0.00045	0.000955	CcSEcCtD
Galantamine—Vomiting—Betamethasone—psoriatic arthritis	0.000447	0.000948	CcSEcCtD
Galantamine—Vomiting—Dexamethasone—psoriatic arthritis	0.000447	0.000948	CcSEcCtD
Galantamine—Decreased appetite—Methotrexate—psoriatic arthritis	0.000444	0.000943	CcSEcCtD
Galantamine—Rash—Dexamethasone—psoriatic arthritis	0.000443	0.00094	CcSEcCtD
Galantamine—Rash—Betamethasone—psoriatic arthritis	0.000443	0.00094	CcSEcCtD
Galantamine—Dermatitis—Betamethasone—psoriatic arthritis	0.000442	0.000939	CcSEcCtD
Galantamine—Dermatitis—Dexamethasone—psoriatic arthritis	0.000442	0.000939	CcSEcCtD
Galantamine—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000441	0.000937	CcSEcCtD
Galantamine—Fatigue—Methotrexate—psoriatic arthritis	0.000441	0.000936	CcSEcCtD
Galantamine—Headache—Dexamethasone—psoriatic arthritis	0.00044	0.000934	CcSEcCtD
Galantamine—Headache—Betamethasone—psoriatic arthritis	0.00044	0.000934	CcSEcCtD
Galantamine—Asthenia—Prednisone—psoriatic arthritis	0.000439	0.000932	CcSEcCtD
Galantamine—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000421	0.000894	CcSEcCtD
Galantamine—Diarrhoea—Prednisone—psoriatic arthritis	0.000418	0.000888	CcSEcCtD
Galantamine—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000418	0.000887	CcSEcCtD
Galantamine—Nausea—Betamethasone—psoriatic arthritis	0.000417	0.000886	CcSEcCtD
Galantamine—Nausea—Dexamethasone—psoriatic arthritis	0.000417	0.000886	CcSEcCtD
Galantamine—Dizziness—Prednisone—psoriatic arthritis	0.000404	0.000859	CcSEcCtD
Galantamine—Abdominal pain—Methotrexate—psoriatic arthritis	0.000404	0.000858	CcSEcCtD
Galantamine—Body temperature increased—Methotrexate—psoriatic arthritis	0.000404	0.000858	CcSEcCtD
Galantamine—Vomiting—Prednisone—psoriatic arthritis	0.000389	0.000826	CcSEcCtD
Galantamine—Rash—Prednisone—psoriatic arthritis	0.000386	0.000819	CcSEcCtD
Galantamine—Dermatitis—Prednisone—psoriatic arthritis	0.000385	0.000818	CcSEcCtD
Galantamine—Headache—Prednisone—psoriatic arthritis	0.000383	0.000813	CcSEcCtD
Galantamine—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000377	0.000799	CcSEcCtD
Galantamine—Asthenia—Methotrexate—psoriatic arthritis	0.000367	0.000779	CcSEcCtD
Galantamine—Nausea—Prednisone—psoriatic arthritis	0.000363	0.000771	CcSEcCtD
Galantamine—Diarrhoea—Methotrexate—psoriatic arthritis	0.00035	0.000742	CcSEcCtD
Galantamine—Dizziness—Methotrexate—psoriatic arthritis	0.000338	0.000718	CcSEcCtD
Galantamine—Vomiting—Methotrexate—psoriatic arthritis	0.000325	0.00069	CcSEcCtD
Galantamine—Rash—Methotrexate—psoriatic arthritis	0.000322	0.000684	CcSEcCtD
Galantamine—Dermatitis—Methotrexate—psoriatic arthritis	0.000322	0.000684	CcSEcCtD
Galantamine—Headache—Methotrexate—psoriatic arthritis	0.00032	0.00068	CcSEcCtD
Galantamine—Nausea—Methotrexate—psoriatic arthritis	0.000304	0.000645	CcSEcCtD
